NorthWest Biotherapeutics Inc (NWBO)

[Slave1]

What’s sufficient for me is the NICE letter Flipper received, which confirms that NWBO is still fully engaged in the MAA process with the MHRA. The most telling line is: “the company are not yet in a position to provide their evidence submission with us.” That matters, because NICE doesn’t begin its role until MHRA has issued a positive opinion. So if NICE is now waiting on NWBO (not the regulator) it strongly suggests the process is in its final phase, likely involving labeling and internal wrap-up. The silence isn’t failure; it’s protocol, just as Linda Powers implied during the ASM. All of it reinforces that we’re structurally exactly where we should be.